American
Society of Transplant Physicians
ASTP 16th Annual Meeting
Abstracts Table of Contents
May 10-14, 1997
Sheraton Chicago Hotel and Towers Chicago, Illinois
Kidneys:
- Is Cyclosporine (CsA,
Sandimmun) Monotherapy an Effective and Safe Immunosuppressant in Renal
Transplant Recipients?
- Impact Of Intra-Patient
Variability Of Blood Cyclosporine Levels On Long-Term Pure Kidney Graft Survival
- Valaciclovir Reduces The
Incidence Of Cytomegalovirus Disease In CMV-Seropositive Renal Allograft
Recipients
- Response To MMF In Patients
With Chronic Renal Allograft Rejection
- Evidence that reducing
maintenance immunosuppression directly affects cancer incidence after renal
transplantation. Prospective and randomized study on two Cyclosporin A (CsA)
dosages.
- The Effect Of Food On The
Oral Bioavailability Of Tacrolimus And The Changes In Pharmacokinetics With Time
Post Transplant In Renal Transplant Patients
- Pretransplant "Booster"
Dose Of A RATG (Anti-Jurkat) Inducing IL-10 Release In Renal Transplantation
- National Transplantation
Pregnancy Registry: Outcomes Of Pregnancies In Female Recipients And Pregnancies
Fathered By Male Recipients On The Three New Maintenance Immunosuppressives
- National Transplantation
Pregnancy Registry (NTPR): Use Of Muromonab-CD3 (OKT3) During Pregnancy In
Female Transplant Recipients
- Pentoxifylline (PTX)
Promotes Replication Of Human Cytomegalovirus (HCMV)
- Cyclosporine And Tacrolimus
Protect EBV-Transformed B Cells From Cell Death
- Chronic Asymptomatic
Hepatitis C In Patients Awaiting Renal Transplant: Assessment Of Histology And
Quantitative HCV By PCR
- Length Of Hospital Stay
(LOS) In Renal Transplant Recipients With Delayed Graft Function (DGF)
- Ionized Serum Magnesium
(Mg2+) & Cardiovascular Risk In Renal Transplant Recipients (RTRS)
- Serologic Responses To
Hepatitis C (HCV) In Solid Organ Transplant Recipients
- Renal Transplant
Recipients Donor Age And Influence Of Immunosuppression On Graft Survival
- Association Between Late
Acute Rejection And Expression Of EBV Early-Antigen Transcripts In B Cells From
Kidney Transplant Patients
- Association Between
Monoclonal Gammopathy (MG) And High Expression Of EBV-Related EBR-1 Transcripts
In B Cells From Transplant Patients
- Quality Of Life In End
Stage Renal Disease Care
- The Influence OF The Rh
Blood Group System On Graft Survival In Renal Transplantation
- Low-Dose Heparin
Prophylaxis In Kidney Transplantation Is Associated With An Increased Incidence
Of Lymphocele Formation
- Evidence Of Subclinical
Pneumonitis During CMV Infection After Kidney Transplantation
- Significance Of Tumor
Necrosis Factor (TNF) Microsatellite Polymorphism In Renal Transplantation
- Evaluation Of Progression
Of Coronary Artery Disease (CAD) In Diabetic Patients Awaiting Renal
Transplantation
- Inferior Outcome Of Kidney
Transplants From Donors Older Than 50 Years Exposed To Prolonged Cold Ischemia
Time
- The Course And
Predictor(s) Of Hepatitis C Virus Associated Liver Disease In Long-Term
Survivors of Kidney Transplantation: The Role Of Viral Genotype And Viral Load
- Renal Allograft
Dysfunction During Acute Hemorrhagic Cystitis
- The Early Diagnosis and
Monitoring of CMV Infection in Renal Transplant Recipients: Comparison Among CMV
Antigenemia Assay, PCR, Serology, and Shell Vial Assay
- Cost-Effectiveness Of
Routine Vs. Selective Use Of Ureteral Stents In Renal Transplant Recipients
- Use Of Donor
Cockcroft-Gault GFR To Predict Cadaveric Transplant Recipient GFR
- Correlation Of Captopril
Magnetic Resonance Renogram, And Perfusion Changes With Severity Of Renal
Allograft Artery Stenosis
- Effective Pre-Transplant
Screening Identifies Contraindications To Renal Transplantation (Tx) And Reduces
Post-Transplant Cardiac Mortality
- Optimal Use In Cadaver
Renal Transplantation Of Kidneys From Less Than Optimal Donors
- Continent Urinary
Diversion and Undiversion in Renal Transplantation for ESRD Patients with Long
Standing Previous Diversion
- Is There Any Positive
Impact on the Bone Mineral Density if We Switch Prednisone to Deflazacort During
the Maintenance Phase of Immuno-suppression in Renal Transplant Recipients?
- Recurrence of Lupus
Nephritis Following Transplantation
- Antiphospholipid Antibody
Syndrome in Renal Transplantation: Occurrence of Clinical Events in 96 Lupus
Patients
- Chronic Rejection of
Cadaveric Renal Allografts: Role of Acute Rejection Episodes
- Prognosis of CMV Infection
After Renal Transplantation
- A Prospective Study of PCR
for Cytomegalovirus (CMV-PCR) in Asymptomatic Kidney Transplant Recipients
- Race-Related Differences
in Clinical Response to Corticosteroid Treatment of Acute Renal Allograft
Rejection among African-American and Non-African American Transplant Recipients
- Adoptive Transfer of
Peanut Allergy with Combined Liver and Kidney Transplantation
- Harmful Long-Term Impact
of HCV Infection in Kidney Transplant Recipients
- Comparison of Vascular
Risk Factors in Diabetic and Non-Diabetic Renal Transplant Patients
- Physical Functioning, Body
Composition and Cardiovascular Risk in Participants in the 1996 U.S. Transplant
Games
- Incidence of Cancer and
Risk Factors in 1570 Renal Transplant Patients During a 25-Year Period
- The Prevalence and Impact
of Hepatitis G Virus on the Post-Transplant Course of Hepatitis C Virus Infected
Renal Transplant Recipients: A Controlled Study
- Glomerular Capillary Wall
Injury Contributes to the Hypofiltration of Human Renal Allografts
- Treatment of
Intraoperative Hypertension with Labetalol should be discouraged during kidney
transplantation
- Determinants of Referral
for Transplantation, Transplantation and Survival on Dialysis in Women
- Role of Nephron Dosing in
Renal Transplantation
- Risk of Post-transplant
Renal Thrombosis in Patients with Anti-phospholipid Antibody Syndrome
- An Evaluation of
Pathologic Criteria for Acute Renal Allograft Rejection: Reproducibility,
Sensitivity and Clinical Correlation
- Blood Nitric Oxide Levels
are Elevated in Acute Renal Allograft Rejection but not in Cyclosporine
Nephrotoxicity
- Effect of Renal Function
on Metabolites of Nitric Oxide in Blood
- The Return of the Kidneys
that Nobody Wanted (KNW)
- Expression of Cytotoxic T
Lymphocyte Genes (CTL) in Peripheral Blood Mononuclear Cells (PBMC) and
Correlation with Rejecting Renal Allografts
- Urinary Tract Infection
Associated with Ureteral Stents in Renal Transplantation
- Long-Term Results and
Complications of Renal Transplantation. Observations in the Third Decade
- Does Mycophenolate Mofetil
Improve Already Good Results from Cyclosporine Induction Early After Renal
Transplantation?
- Histomorphometric
Assessment of the Number and Size of Glomeruli in the Donor Kidney Predicts
Early Allograft Function after Renal Transplantation.
- Selection Bias in Renal
Transplantation: Correlation of Physician Choice with a Computer Based Algorithm
in a Single Centre
- Living Donors (LD'S) Age >55;
To Use or Not to Use?
- Banff Classification
Analysis of Renal Morphology in Clinical Trials of Tacrolimus (FK506) vs.
Cyclosporine (CsA) in Renal Transplantation
- Factors Predictive of
Early Allograft Loss in Recipients of Kidneys from Marginal Donors
- Characteristics of
Long-Term Renal transplant Survivors
- Variables Associated with
Graft Loss Following Pregnancy in Cyclosporine-Treated Female Kidney Transplant
Recipients
- A Blinded Retrospective
Analysis of Renal Allograft Pathology Using the Banff Schema: Implications for
Clinical Management
- Incidence and Risk Factors
for Renal Allograft Nephrectomy Prior to and After 6 Months Posttransplant
- The Effect of HLA Matching
on the Risk of Mortality for Kidney Recipients: A Comparison of the Risk
Post-Transplant to the Risk of Remaining on the Waiting List
- Fate of Transplanted
Elderly Donor Kidneys in Young and Older Adult Recipients
- Parvovirus B19
Infection-Related Complications in Renal Transplant Recipients: Treatment with
Intravenous Immunoglobulin
- Treatment of Onychomycosis
in Transplant Recipients with Weekly Fluconazole - A Pilot Study
- Impact of Focal Segmental
Glomerulo Sclerosis after Renal Transplantation: A Report from the Renal
Allograft Recurrent Disease Registry (RARDR)
- The Great Success of Asian
Women - The Effect of Race on Renal Allograft Outcome
- Prevalence and
Significance of Hepatitis Viruses C & G in Allograft Recipients
- Use of Allografts from
Donors Positive for Hepatitis B Core Antibody Confer Minimal Risk for Subsequent
Development of Hepatitis B Virus (HBV) Infection
- The Disappearing Face of
Acute Rejection
- Prognosis and Outcomes for
Patients who Reject a Renal Transplant and Return to Dialysis
- Mortality Related to Viral
Hepatitis in Renal Allograft Recipients, How Significant a Problem?
- Continuous Ambulatory
Blood Pressure Monitoring (ABPM) in Post Nephrectomy Living Kidney Donors:
Method of Analysis and Preliminary Data
- Recurrent and De-novo
Glomerular Disease after Renal Transplantation: A Report from the Renal
Allograft Recurrent Disease Registry (RARDR)
- Clinical Significance of
Positive Cytomegalovirus Urine Culture in Renal Transplant Patients with
Cytomegaloviral Septicemia
- Outcome of Renal
Transplantation in Patients with Renal Cell Carcinoma and Von Hippel Lindau
Disease
- Ultraviolet-B Irradiated
Donor-Specific Leukocyte Transfusion in Clinical Renal Transplantation
- Post Renal Transplant (TX)
Health Beliefs - Racial Variations
- Long Term Outcome of
Cadaver Kidney Transplantation from Expanded Criteria Donors - A Single Center
Experience
- Transplant Glomerulopathy:
Relationship with Long Term Arterial Hypertension
- A New Approach to the
Treatment of Chronic Allograft Nephropathy
- Increased Incidence of
Postoperative Infections Associated with Peritoneal Dialysis in Renal Transplant
Patients
- Prognostic Significance of
Eosinophils on Renal Allograft Biopsy with Acute Rejection
- Prevention of Renal
Transplant Thrombosis: Detection of "Hypercoagulability" in Renal
Transplant Candidates
- Incidence and Treatment of
Post-Transplant Leukopenia
- Clinical efficacy of
transdermal testosterone (TT) in post-transplant hypogonadal impotence
- Time on Dialysis (Dtime)
Prior to Renal Transplantation (Tx) correlates with Patient Survival Post-Tx
- Analysis of Complications
in Obese Living Kidney Donors
- Posttransplant
Hyperlipidemia does not Correlate with Atherosclerotic Complications after
Kidney Transplant (KTx)
- Evidence that the
Intensity of Acute Rejection, Independent of Rejection Number, Predicts the Rate
of Graft Loss in Kidney Allograft Recipients
- Post-Transplant Diastolic
Hypertension: Etiological Correlation with Intragraft TGF-ß and Renin
Transcription
- Analysis of the OKT3
Associated Cytokine Release Syndrome in 1047 Patients: Factors Predicting
Adverse Events
- Cadaveric Allogenic
Skeletal Muscle Transplantation in a Renal Transplant Patient: Results and
Implications
- Bilateral Native
Nephrectomies: Indications and Effect on Hypertension in the Cyclosporine Era
- Potential Determinants of
the Post-Methionine Loading Increase in Total Plasma Homocysteine Levels Among
Stable Renal Transplant Recipients
- Results of the Secuential
Biopsies (Bx) Protocol in Grafted Kidneys
- Long-Term Follow-up of
Living Organ Donors
- Tuberculosis in Kidney
Transplant Recipients
- HCV Infection in Kidney
Transplant Patients: Evaluation of Histological Activity Index in Prospective
Biopsies
- Correlation of Post
Treatment Renal Allograft Biopsies to Rejection Reversal
- The Utility of
Pre-Transplant Renal Biopsy in High Risk Donors: Can We Safely Increase the
Donor Pool
- Lack of Phenotypic
Difference in the Cellular Infiltrate Between Subclinical and Clinical Allograft
Rejection
- Early Predictors (0-6
Months) of Decreased Renal Function 24 Months Post Transplant
- Treatment of Early
Subclinical Rejection (SR), Improves Renal Function at 24 Months (MO) in
Recipients of Kidneys from Older Donors
- Chronic Cyclosporine
Nephrotoxicity is Not Clinically Relevant in Long Term Allograft Function or
Survival
- Impact of Donor Age Older
65 Years on Renal Transplant Survival and Function: A Case Control Study
- Renal Transplantation in
The Elderly: A Single Center Case Control Study of Graft and Patient Survival in
91 Patients Older than 65 Years
- Renal Transplant Patients
with HCV Infection have Less Rejection and Excellent Survival Figures with a
Less Aggressive Immunosuppressive Protocol in Spite of a Higher Incidence of
Severe Infections
- Fibrosing Hepatitis with
Cholestasis in Hepatitis C Virus (HCV) Infected Patients. A New, Early and
Severe Complication after Renal Transplantation
- Immediate Graft Function
is Strong Prognostic Factor of Long Term Graft Survival Rate
- Pregraft Sera Induced
Alteration of Glomerular Permselectivity Does Not Predict Recurrence of
Idiopathic Nephrotic Syndrome (INS) After Renal Transplantation
- Venous Thromboembolic
Complications after Kidney and Kidney-Pancreas Transplant—A Multivariate
Analysis
- Risk Factors for
Accelerated Atherosclerosis in Renal Transplant Recipients (RTR): A Prospective
Study
- Use of VCS Vascular Clips
Means Less Warm Ischemia in Kidney Transplants
- Elevated Serum Creatinine:
A Valuable Objective Measure of Delayed Graft Function in Renal Transplants
- Tubular Antithrombin in
Donor Kidneys and Early Renal Allograft Function
- Recurrent Focal Segmental
Glomerulosclerosis is Mediated in Part by Enhanced Expression of Gelatinase B in
Endothelial Cells
- Pre Transplant
Intervention To Prevent Recurrence of Focal Segmental Glomerulosclerosis (FSGS)
in High Risk Patients
- Impact of Hepatitic G
Virus - HGV - Infection - In Hepatitis C Virus - HCV+ve-Renal Transplant
Patients
- Iterative Liver Biopsies
in HCV+ve Renal Transplant Patients
- Glucose Metabolism,
Insulin- and C-Peptide Secretion Capacity in the First 2 Years After Renal
Transplantation: Even Stressed no Difference Between FK506 and Cyclosporin A!
- Preexistent Sclerotic
Lesions in Donor Kidney: No Influence on Long-term Graft Survival and Function
- 'Transplant Esophagitis':
Microbiological, Pathological, and Clinical Correlates in a Series of 97
Episodes in Kidney and Pancreas Tx Recipients
- Indirect Allorecognition
of MHC Allopeptides in Human Renal Transplant Recipients with Chronic Graft
Dysfunction
- Differential Diagnosis of
Cytomegalovirus (CMV) Diseases and Rejection Episodes in Kidney Transplantation
- P53 Immunoreactivity in
Skin of Renal Allografted Patients
- Lymphocyte Subsets and
Langerhans Cells in Sun-Protected and Sun-Exposed Skin of Immunosuppressed Renal
Allograft Recipients
- Acute Vascular Rejection -
A Clinical and Morphological Study
- Contribution of the
Expression of ICAM-1, HLA-DR and IL-2R to the Fine-Needle Aspirative Cytology
Diagnosis of Acute Rejection in Renal Allografts
- Use of Gadolinium Enhanced
Time of Flight Magnetic Resonance Angiography in the Preoperative Evaluation of
Living Renal Allograft Donors
- Effect of HCV Genotype on
Patient and Graft Survival in Renal Transplant Candidates
- Predictors of GB Virus-C
(GBV-C) Infection in Patients Referred for Renal Transplantation
- Impact of GB Virus-C
(GBV-C) Infection on Clinical Outcomes in Renal Transplantation (Tx) Candidates
- En-Bloc Kidney
Transplantation from Donors Less Than Five Years
- Long-Term Effects of Mono-
and Polyclonal Antibodies on Lymphocyte Subsets and Kidney Graft Function
- The Natural History of
Renal Transplantation in Patients with Polycystic Kidney Disease: The True
Incidence of Chronic Rejection
- The Impact of Cyclosporine
Delivery on Chronic Rejection in Kidney Transplantation
- Autonomic Dysregulation in
Patients Awaiting Kidney Transplantation
- A Phase III Multi-Center
Study of Humanized Anti-Tac (HAT) for the Prevention of Rejection in Primary
Cadaveric Renal Allograft Recipients
- Reduction of Acute
Cellular Rejection in Renal Allograft Patients with Basiliximab (Simulect™)
- Mycophenolate Mofetil for
the Treatment of First Acute Renal Allograft Rejection
- Effect of HCV Genotype on
Patient and Graft Survival in Renal Transplant Candidates
- Living Unrelated Renal
Transplantation in Children: Report of the North American Pediatric Renal
Transplant Cooperative Study (NAPRTCS)
- High Level Gene Expression
in Rat Kidney Transplants Using Naked DNA
- Selective Hyperexpression
of Immunosuppressive Cytokine Transforming Growth Factor-ß1 (TGF-ß1)
in Organ Graft Recipients Preconditioned with Cyclosporine (CsA)
- Intrarenal Expression of
Interlukein-10 (IL-10): A Molecular Correlate of Acute Rejection of Human Renal
Allografts
- The Usefulness of OKT3
Induction Following Cadaveric Kidney Transplants in Insulin-Dependent Diabetics
- Post Renal Transplant
Kaposi Sarcoma (KS): Association with Antibodies to Recombinant Capcid Antigen
of Kaposi's Sarcoma - Associated Herpes Virus (KSHV) in Saudi Arabian (KSA)
Renal Transplant Recipients (RTR)
- Cytomegalovirus
Leukocytic Viral Load Determination Using Direct Detection of Antigenemia by
Flow Cytometry and Quantitative-Competitive PCR
- Azithromycin Treatment of
CsA-Induced Gingival Hyperplasia in Renal Transplant Recipients
- Renal Replacement Therapy
for HCV-Infected ESRD Patients: Dialysis or Transplantation
- Excess Prevalence of
Fasting and Post-Methionine Loading Hyperhomocysteinemia in Stable Renal
Transplant Patients
- The Living Donor (LD)
Process in Kidney Transplantation (txp): Influence of Race and Comorbidity
- Mitogen Induced TH1
Responses in Peripheral Blood of Renal Allograft Recipients Correlates with the
Presence of Acute and Chronic Rejection
- Effect of Long-Term
Immunosuppression on HCV Seropositive Renal Transplant Recipients
- Biological Moniforing of
Stable Renal Allografts: Chronic Rejection Is Sublinical Acute Rejection
- Predominant TH1 Cell
Infiltration In Acute Rejection Episodes of Human Kidney Grafts: Correlation
Between InVitro IFN-y Production and Infiltration
Immunosuppression:
- Clinical And Histological
Evolution Of Acute Cellular Rejection Treated With Two Different Doses Of
Methyiprednisolone
- Intra-Individual
Variability Of Cyclosporine Exposure: A Significant Risk Factor For Rejection
- Correlation Between
Pre-Transplant Cyclosporine Pharmacokinetic Parameters and Post-Transplant
Sirolimus Concentrations In Renal Transplant Recipients
- Selective In Vivo Deletion
Of Alloactivated TH1 Cells By OKT3 MAB In Acute Rejection
- The Immunoregulatory Role
of CD26/Dipeptidyl Peptidase IV Activity In Acute Allograft Rejection Response
- Geldanamycin Induced
Protein Tyrosine Kinase Loss In T-Cells. A Novel Anti-Rejection Therapy?
- Prolonged Liver Allograft
Survival By Injection Of Autologous Hepatocytes Genetically Modified To Express
Soluble Donor-MHC Class I Antigen
- Evidence For In Vivo
Immunosuppression After Injection Of Autologous Hepatocytes Expressing Soluble
Class I Antigen
- Alloreactive CTL Activity
Inhibited By Soluble HLA May Be Mediated By Apoptosis
- Anti-CD4 Monoclonal
Antibody-Induced Allograft Tolerance Despite Persistence Of Donor-Reactive T
Cells
- Biochemical And Biological
Mechanisms Of Suppression By FCR Non-Binding Anti-CD3 MABS
- Characterization and
Biological Significance of an Allotrap Peptide B2702 (E>V) Binding Protein -
Isolation of Heme Oxygenase I.
- Co-Administration of
Tacrolimus (T) and Mycophenolate Mofetil (MMF) May Result in Higher MPA Exposure
- Clinical Evaluation of an
Improved Sensitivity Tacrolimus (FK506) Assay by Microparticle Enzyme
Immunoassay
- Pharmacokinetics of
Simulect in Recipients of Cadaver Kidney Transplants
- Anti-Thymoglobulin IgG and
Anti-Atgam IgG in Renal Transplant Patients Undergoing Treatment for Acute
Rejection
- A Randomized Study of
BTI-322 for the Prevention of Renal Allograft Rejection: One Year Follow Up
- Cyclosporine Exposure and
Pharmacokinetic Variability in a Randomized, Prospective Multicentre Study of
Neoral in Stable Renal Transplantation
- Sirolimus (SRL) Permits
Early Steroid Withdrawal from a Triple Therapy Renal Prophylaxis Regimen
- The 1996 Double Blinded
Randomized Multicenter Phase III Clinical Trial of the Thymoglobulin Versus
Atgam in the Treatment of Acute Graft Rejection Following Renal Transplantation
- 18A Pharmacokinetic
Comparison of SangStat Cyclosporine Formulation 35 and Sandoz Neoral in Healthy
Volunteers in Two Pilot Studies
- Racial Differences in
Kidney Transplantation: Results of a U.S. Multicenter, Randomized Trial
- Safety, Tolerability, and
Pharmacokinetics of the New Immunosuppressant SDZ Rad in Stable Renal Transplant
Recipients
- Sang-35 Cyclosporine
Formulation is Bioequivalent to Neoral Cyclosporine Formulation in Pivotal
Healthy Volunteer Trial
- Both Sang-35, A Novel
Cyclosporine Formulation, and Neoral Result in Low Pharmacokinetic Variability
in Healthy Volunteers
- Cyclosporine 2-hour Peak
Level: A New Tool for Neoral Dose Monitoring
- Concomitant Administration
of Antacids and Tacrolimus (T) Did Not Alter T Absorption in Normal Volunteers
- A Randomized, Prospective,
Comparative Study of Tacrolimus-Mycophenolate Mofetil and Neoral-Mycophenolate
Mofetil in Kidney Transplantation
- A Prospective, Randomized
Trial of Tacrolimus/Prednisone Versus Tacrolimus/Prednisone/Mycophenolate
Mofetil in Cadaveric Renal Transplantation-First Report
- Effect of FK506 Based
Maintenance Therapy in Highly Sensitized Renal Allograft Recipients
- Tacrolimus in Kidney
Transplantation: Two-Year Results of the U.S., Randomized, Comparative, Phase
III Study
- Analysis of T Cell Immune
Functions in Renal Transplant Patients Treated with Humanized anti-Tac (HAT)
Monoclonal Antibody
- Effect of Relative Timing
of Sirolimus and Cyclosporine (Neoral) Co-Administration on the Pharmacokinetics
of Each Agent
- Randomized Clinical Trial
of Anti-LFA-1 Monoclonal Antibody in Cadaveric Renal Transplantation: A European
Multicenter Study
- Results of the Randomized
Trial of Mycophenolate Mofetil vs Azathioprine in Heart Transplantation
- Comparison of the IMx®
MEIA and PRO-Trac™ II ELISA Assays for the Determination of Tacrolimus
(Prograf®, FK506) in Whole Blood
- An Open Labeled Single
Center Bioequivalence Comparison of Sandimmune® and Neoral® versus
Sang-35 Cyclosporine
- Primary Immunosuppression
with FK506 (FK) and Mycophenolate Mofetil (MMF) for Renal Allograft Recipients
- Primary CMV Disease
Prophylaxis: No Benefit from the Addition of CMV Immune Globulin to High Dose
Acyclovir and Targeted Ganciclovir in Kidney and Kidney/Pancreas Transplantation
- The Outcome After Steroid
Withdrawal in Renal Transplant Patients Receiving Tacrolimus-Based
Immunosuppression
- Effects of Tacrolimus
(Prograf) on Hyperlipidemia after Successful Renal Transplantation: A SEOPF
Multicenter Clinical Trial
- Mechanisms of Improved
Bioavailability of Cyclosporin Neoral in Renal Transplant Patients With and
Without Hepatic Dysfunction
- Comparative
Pharmacokinetic (PK) Study of Sandimmune (SN) and Neoral (NL) CsA in Renal
Transplants With and Without Hepatic Dysfunction
- Renal Transplantation with
Mycophenolate Mofetil (MMF) and OKT3 Induction Therapy: A Comparison of Low Dose
vs. Standard Dose
- Hepatic CYP3A4 is the
Principal Determinant of Neoral® Pharmacokinetic Variability
- Assessment of
Health-Related Quality of Life in Kidney Transplant Patients Receiving
FK506-based Versus Cyclosporine-based Immunosuppression
- Efficacy of OKT3 as
Primary Therapy for Histologically Confirmed Acute Renal Allograft Rejection
- Elective Conversion of
Sandimmune to Neoral in Stable Renal Transplant Recipients
- Colchicine - Cyclosporine
(CSA) Interaction in Renal Transplant Recipients
- Steroid Withdrawal: Is
Later and Slower Steroid Tapering Better?
- Thymoglobulin Successfully
Prevents Recurrent Rejection
- Thymoglobulin is Effective
in Reversing Resistant Acute Rejection in Transplant Recipients
- A Randomized, Prospective
Multicentre Pharmaco-Epidemiologic Study of Neoral (Cyclosporine Microemulsion)
in Stable Renal Graft Recipients: Results at 18 Months
- Use of Alternative
Medicine by Renal Transplant Recipients
- Mycophenolate Mofetil
(MMF) Therapy for Chronic Rejection in Renal Transplant Recipients
- A Six Month Follow-Up of
Kidney Transplant Patients Converted to Neoral
- Improved Renal Allograft
(Tx) Survival with More Intense Immunosuppression in Black Recipients
- The Experience of
Administration of 15-Deoxyspergualin (DSG) for Various Type of Rejection in
Renal Transplantations (Tx)
- Mycophenolate Mofetil for
the Treatment of First Acute Renal Allograft Rejection
- A Long-Term Randomized
Multicenter Study of Mycophenolate Mofetil (MMF) in Cadaveric Renal
Transplantation: Results at 3 Years
- First-Line Antilymphocyte
Antibody Therapy Followed by Conversion from Cyclosporine to Tacrolimus
Minimizes Risk of Recurrent Rejection in Renal Allograft Recipients
- Mycophenolate Mofetil: In
Cadaveric Renal Transplantation: 3-Year Data
- Thymoglobulin Serum Levels
in Renal Transplant Patients Undergoing Treatment for Acute Rejection
- Five Year Follow Up of A
Prospective, Randomized Double-Blind Study Comparing Standard Versus Low Dose
OKT3 Induction Therapy in Renal Allograft Recipients
- Cyclosporine (CSA)
Requirement is Reduced and Creatinine Increases After Conversion from Sandimmune
(SAND) to Neoral (NEOR), Except in Patients (PTS) Taking Diltiazem or Verapamil
(CCB's)
- Prednisone (PRED) Area
Under the Curve (AUC) is Increased by Diltiazem (DILT) with Effects on
Circulating T Cell (TC) Markers
- Is Cytomegalovirus (CMV)
Infection Related to Mycophenolate (MMF) After Kidney Transplantation? A
Case-Control Study
- Prophylactic Oral
Ganciclovir Prevents Cytomegalovirus Infection and Disease in Renal Transplant
Recipients
- Maintenance of High Trough
Cyclosporine (CY) Levels Results in a Low Incidence of Acute Rejection in Renal
Transplants
- Selective Steroid
Withdrawal (SW): Long Term Renal Transplant Survival and Clinical Benefits
- The Effect of Aerosol
Cyclosporine on Local and Systemic Cytokine and iNOS Gene Expression in
Experimental Pulmonary Transplantation
- Tacrolimus (FK506) and
Sirolimus (RAPA) in Combination are not Antagonistic but Produce Extended Graft
Survival in a Rat Heart Allograft Model
- Reversal of Ongoing
Rejection by Monoclonal Antibody Against LFA-1 and VLA-4 in a Mouse Heart
Allograft Model
- Thymoglobulin is More
Effective than ATGAM in Maintaining T Cell Depletion During and Following
Therapy
- Blockade of VLA-4
Integrin-Fibronectin Adhesive Interactions In Vivo: A Novel Approach To Prevent
Chronic Rejection In Sensitized Graft Recipients
- Il-4 Induces A Mixed
TH1/TH2 Allospecific T Cell Response That Mediates Graft Rejection
- Successful Rational
Design of Novel Immunosuppressive Compounds
- The Antiproliferative
Effect of SP100030, A Novel and T Cell Specific Dual Inhibitor of NF-kB and
aP-1, On Murine Splenocytes In Vitro Appears To Be Mediated by Inhibition of
IL-2 Production
- In Vivo Effects of
Humanized Anti-Rhesus LFA-1 Monoclonal Antibody In Nonhuman Primates
- BTI-322, An Anti-Human
CD2 MAB, Elicits Specific Depletion of T Cells Activated By Anti-TCR Vß
MAB
- Tacrolimus Induces TGF-b1
In Human T Cells
- Prevention of
Graft-Versus-Host Diseases (GvHD) In Rodents By The New Immunosuppressants:
Malononitrilamides (MNAs)
- Blocking Adhesive
Interactions Between VLA-4 Integrin and Fibronectin Abrogates Acute Rejection By
Suppressing Intragraft Mononuclear Cell Infiltration, Endothelial Activation and
Cytokine Production
- Novel Intragraft Cellular
Mechanisms Associated With Xenoject Technology: Redirecting Anti-FITC Antibodies
To Target Th1 Cells By Treating Mouse Cardiac Allograft Recipients With
Il-2-FITC
- Idarubicin-Anti-CD3: A
New Immunoconjugate That Induces Alloantigen-Specific Tolerance In Mice
Organ Procurement:
Gene Therapy:
Immunobiology:
- Effect Of Cyclosporin And
FK506 On Insulin Actions In H-411E Cells
- Cyclosporine (CsA)
Increases IkBa Gene Transcription In Human Peripheral Blood Mononuclear Cell
(PBMC)
- Vitamin E And Curcumin
Inhibit Epstein-Barr Virus-Induced Human B-Cell Immortalization
- Gene Transfer Using
Recombinant Adeno-Associated Virus: Stable Insulin Expression In Vitro
- The Expression And Function
of Integrin Adhesion Molecules On Human Islet Cells: Developing A Novel
Approach To Islet Transplantation
- Non-Conventional T Cell
Stimulation By Endothelial Cells And Macrophages
- Characterization Of
CMV-Specific T Helper Memory Responses
- CD4-Ligand Binding Blocks
Interleukin-2 Receptor Signaling And Interleukin-2-Stimulated Interferon-Gamma
Biosynthesis
- Dipeptidyl Peptidase IV
(CD26) Function Varies Between Alloreactive CD4+ And CD8+ T Cell Clones And Is
Influenced By The Cellular Activation Status
- CD2 Is Specifically
Involved In CD3e-mediated T Cell Receptor Trafficking: Combined Modulation Of
CD2 And CD3e Impairs TCR Recovery After Stimulation
- Analyzing T Cell Responses
Using Measurements Of Mitotic Number
- IL-2 Modulates Fas Ligand
Expression In Resting But Not Activated Co-Stimulator Depleted CD4+ T-Cells
Inhibiting TCR Mediated Cell Death
- T Cell Activation Can Lead
To Either Cell Survival Or Apoptosis: Resolution Of The Paradox By The
Demonstration Of Reciprocal Regulation Of Bc1 Gene Family Members
- Identification Of A
Functional, Allospecific T Lymphocyte Subset That Is Resistant To Cyclosporine
- Differences In Fas and
Fas-Ligand Expression In Cardiac Allograft Tissue Using Mice Deficient In
Intercellular Adhesion Molecule-1 (ICAM-1) As Donors or Recipients
- Bone Marrow Derived Cells
Are Responsible For The Tolerogenic Effect Of Lewis To DA Liver Allografts
- Donor Specific Allograft
Tolerance Induced By A Short Course Of Cyclophosphamide
- A Novel Suppressor Cell
Pathway Induced By Intrathymic Inoculation Of Adenovirus Infected Hepatocytes
- Survival Of Accommodated
Cardiac Xenografts Upon Re-Transplantation Into Secondary Hosts
- Intracellular Signals
Associated With T Cell Hyporesponsiveness In TCR Transgenic Mice
- Tolerance In IL-4 Knockout
Recipients: Primary And Secondary Graft Acceptance Can Occur Without TH2
Responses Mediated By IL-4
- BALB/c To CBA Murine
Cardiac Allografts: Tolerance Alters Cytokine Expression But Does Not Prevent
Vascular Thickening And Chronic Rejection
- Dietary Amino Acid As New
And Novel Agents To Enhance Allograft Survival
- "Infectious Tolerance"
Induced By CD45RB Monoclonal Antibody
- Critical Requirement For
Graft Interstitial Dendritic Cells In Allograft Tolerance Induced By Donor-Blood
Transfusion
- CD95L Down Regulation In
Allograft-Tolerance Induced By Donor-Specific Transfusion: A Role For CD95L In
Allograft Rejection
- Immunosuppressive Effects
Of Donor Bone Marrow Cell Infusions In Renal Transplant Recipients
- Selective Expression Of
Th2 Cytokines IL-4 And IL-13 In Cardiac Allografts With Or Without Induction Of
Functional Tolerance
- Autoimmune Tolerance
(AIT): New Perspective On Immunomodulation Preventing Autoimmune Disease
Recurrence (ADR) Following Islet Transplantation (IT)
- Studies Of Allograft
Tolerance (AT) In Class I And Class II MHC Deficient Transgenic Mice Without
Immunosuppression (IS)
- Critical Effect Of Islet
Culture (IC) On Induction Of Operational Tolerance (OT) To Allogeneic Pancreatic
Islets (API)
- Expression Of
Proliferating Cell Nuclear Antigen (PCNA) In Spleens Of Rats With Transplanted
Hamster Hearts: Effect of Immunosuppressants
- Conclusion: The expression
of PCNA is upregulated during xenograft rejection. Lef monotherapy or combined
with CsA significantly inhibited PCNA expression in the white and red pulp,
while CsA inhibited PCNA expression only in the PALs.
- Prolonged Acceptance Of
Pig Xenografts Without Severe Immune Deficiency
- Lysis Of Porcine
Endothelium By IL-2 Activated Primate Mononuclear Cells Involves Interactions
With Galactose a1,3-galactose
- .
- A Platelet Activating
Factor Receptor Antagonist (BN 52021) Prevents Hyperacute Rejection In A Pig
Kidney-Human Blood Xenoperfusion Model
- Antibody Mediated
Apoptosis of Endothelial Cells In A Concordant Cardiac Xeno-Transplant Model
- Induction Of Accommodation
Requires Only Brief Inhibition Of Complement
- CD4 T Cells Are Sufficient
For Acute Cardiac Allograft And Xenograft Rejection
- Immunohistopathology of
Delayed Cardiac Xenograft Rejection In Untreated Newborn Recipients: What Awaits
When Hyperacute Rejection Is Solved
- Use of Synthetic Peptides
From HLA-B2702 Prolongs Survival of Porcine Islet Xenografts In Autoimmune And
Non Autoimmune Murine Diabetes
- Human Xenoreactive Natural
Antibodies, In The Absence of Complement, Activate Porcine Endothelial Cells
Leading To Increased Adhesion And Activation Of Human Neutrophils
- Distinguishing Baboon CMV
From Human CMV: Importance For Xenotransplantation
- New Approach To
Downregulate The Complement Activity On Swine Endothelial Cell
- Losartan Prevents
Progressive Allograft Injury in the F344®LEW Rat Model of Late Renal
Allograft Failure
- Antisense ICAM-1
Oligodeoxynucleotides Block Allograft Rejection in Rats When Used as Pre- or
Post-Transplant Therapy
- Inducible Nitric Oxide
Synthase (iNOS) is not Required for Efficient Rejection of Cardiac Allografts
- Humoral Rejection of
Non-Vascularized Grafts: The Impact of Local Complement Activation on Corneal
Allo- and Xenograft Survival
- Heat Shock Protein-Induced
Immune Response: Its Role in Warm Ischemic Injury
- Contribution of Local C6
Production to Cardiac Allograft Rejection
- A Soluble Form of FAS/CD95
May Modulate Fas-Induced Apoptosis in the Liver
- Genetically Determined
Leukotriene B4 Production is Not Required for Cytotoxic Effector Cell
Development During Allograft Rejection
- Prevention of Accelerated
Rejection in Sensitized Allograft Recipients by Specific Inhibition of
CD26/Dipeptidyl Peptidase IV Activity
- Efficacy of
Immunosuppressive Agents Corresponds to their Ability to Maintain Graft Donor
Phenotype in a Model of Chronic Lung Rejection. A Novel Mechanism of
Immunosuppressive Drug Action?
- The Effect on Rat Cardiac
Allograft Survival When Nutritional Immunomodulation is Combined with
Mycophenolate Mofetil, Cyclosporine A, and Donor-Specific Transfusion
- Detrimental Effect of
Cyclosporine on Cardiac Allograft Survival in CD45RB Treated Mice
- The Impact of
Mycophenolic Acid (MPA), CsA, and FK506 on Human Bone Marrow Infusions
Accompanying Organ Transplantation
- Long-Term Murine Islet
Allograft Survival with FTY 720
- Long-Term Follow Up After
Heterotopic Transplantation - The Emory Experience
- Cells Within Liver
Allografts Inducing Second-set Rejection Are Sensitive to Low Dose Irradiation
and Dependent for Function on MHC Class I Antigen Expression
- Allograft Rejection In
Kidneys Lacking Normal MHC Expression
- Selection of T Cell
Clones With Restricted TCR-CDR3 lengths during In Vitro and In Vivo
Alloresponses
- CD3 and NKR-P1, Two
Unusual Surface Markers of Rat Dendritic Cells
- Hyperinsulinemia and
Cardiovascular Risk (CVR) Factors
- In Vivo Immune Responses
To Allogeneic Hepatocytes (HC) In a Murine Hepatocyte Transplant (HxTx) Model
- CD4 T Cells Are
Sufficient For Cardiac But Not Pancreatic Islet Allograft Rejection
- NOD-SCID Mouse Model for
In Vivo Assessment of Human Islet Function
- Apoptosis in Rejecting
Allografts Can Be CD8-Independent
- Selectively Designed
Class I MHC Proteins Modulate Graft-Versus-Host and Host-Versus-Graft Immune
Responses in Rat Small Bowel Transplant Recipients
- A Functional Antigen -
Presenting Cell (APC) Knockout: A Study of the Class II Deficient (C2D) Mouse
Reconstituted with CD4 Cells
- Long-Term Inhibition of
the Development of Obliterative Airway Disease (OAD) By Brief Anti-LFA-1
Monoclonal Antibody Monotherapy In A Murine Heterotopic Airway Transplant Model
- Persistent Immunologic
Destruction of Tubules and Peritubular Capillaries Is Associated With
Progressive Interstitial Fibrosis In Chronic Rejection
- Infiltrating Recipient
Cells Form The Obliterative Airway Disease Lesion and Dramatically Remodel Graft
Tissue In A Model of Chronic Lung Rejection. A Novel Mechanism Of Graft
Rejection?
- Blockade of CD11a
Ameliorates Severe Reperfusion Injury But Not Chronic Graft Vascular Disease
- Murine Cardiac Allografts
Placed In Interferon-y Knockout Recipients Develop High Levels of Intimal
Thickening and Inflammatory Activation
- Cardiac Allografts Placed
In Interleukin-4 and -10 Knockout Recipients Develop Intimal Thickening and
Cytokine Activation Independent of These Th-2 Cytokines
- Antibodies Against
Mesangial Cells and Their Secretory Products In Rats With Chronic Renal
Allograft Rejection
- Identification of Genes
Upregulated In Ischemia-induced Graft Arteriosclerosis
- Elevated Endothelin-1 and
ETB Receptor Expression In Renal Transplant Recipients With
Transplantation-Associated Arteriosclerosis
- TGF-Beta1 Hyperexpression
In A Rat Cardiac Allograft Model Of Chronic Vascular Rejection
- Localization of
Upregulated IL-15 Translation In Human Renal Allografts During Chronic Rejection
- IL-15 Gene Activation &
Protein Expression In Chronic Ductopenic Rejecting Human Liver Allografts
- Intragraft Expression Of
Chemokine Genes and Identity Of Effector T Cells During Rejection Of Grafts With
Multiple Minor Histocompatibility Differences
- Mechanism of Action of
Viral Il-10 in a DTH Model
- TH1 and TH2 Cytokine
Expression In A Model Of Central Tolerance
- Systemic Administration
of Low Dose IL-10 Before Cardiac Transplantation is Beneficial To Graft Survival
- Monocytes-Macrophages and
cytokines/chemokines in fine-needle aspiration biopsies (FNAB) cultures:
enhanced IL-1ra synthesis in rejection-free kidney transplant (Tx) patients.
- Regulated Endothelial and
Epithelial Production of the T Cell Growth Factors IL-12 and IL-15 May Promote
Alloreactivity
- Adenovirus-Mediated Gene
Transfer In Rat Liver of Interleukin-4 (IL-4) But Neither Interleukin-10 (IL-10)
Nor Transforming Growth Factor-ß (TGF-ß) Induces Hepatitis.
- Chemokine Expression In
Xenogeneic and Allogeneic Heterotopic Cardiac Transplant Models
- Mechanism of
CD8-Dependent Rejection Of Pancreatic Islet Allografts
- Prolongation of Renal
Allograft Survival With CTLA4-IG In The Rhesus Macaque
- Effects of Hydrophobic
Extracts From A Chinese Herbal Preparation (CMX-13) On Human T-Cell
Proliferation and Cytokine mRNA Levels In Vitro
- Immunosuppression
Preventing Concordant Xenogeneic Islet Graft Rejection Is Not Sufficient To
Prevent Recurrence of Autoimmune Diabetes In NOD Mice
- DNA-Liposome Versus
Adenovirus Mediated Gene Transfer Into Vascularized Cardiac Transplants
- In Vivo Mechanism By
Which Leflunomide Controls Lymphoproliferative and Autoimmune Disease In
MRL/MpJ-lpr/lpr MICE
- Enhanced
Immunosuppressive Activity of HLA Class I Heavy Chain (Amino Acid 75 to 84)
Derived Peptides By Amino Acid Substitutions
- Elucidation of the
Molecular Mechanism By Which Leflunomide (LFM) Prolongs Graft Survival In Vivo:
Inhibition of Dihydroorotate Dehydrogenase (DHODH) Activity and Pyrimidine
Biosynthesis
- Intragraft Expression Of
Chemokine Genes and Identity Of Effector T Cells During Rejection Of Grafts With
Multiple Minor Histocompatibility Differences
- Mechanism of Action of
Viral Il-10 in a DTH Model
- TH1 and TH2 Cytokine
Expression In A Model Of Central Tolerance
- Systemic Administration
of Low Dose IL-10 Before Cardiac Transplantation is Beneficial To Graft Survival
- Mycophenolic Acid
Influences Th2-Cytokine Induced Expression of ICAM-1 on Human Endothelial Cells
- Adenovirus Mediated
Expression of Fas Ligand Induces Hapatic Apoptosis After Systemic Administration
and Apoptosis of Ex Vivo Infected Pancreatic Islet Allografts and Isografts.
- Prevention of Acute Rat
Heart Allograft Rejection By Leflunomide (LFM): Study of Relationships Among
Drug Dose, Treatment Schedule, Pharmacokinetics (PK), Pharmacodynamics (PD) and
Grade of Rejection
- Donor Pretreatment With
Mycophenolate Mofetil Protects Against Ischemia-Reperfusion Injury In The Rat
- Malonitrilamides (MNAs)
Suppress T- and B-Cell Proliferation and Antidonor Antibody Synthesis In Vivo
and Therapy Preventing Acute and Ongoing Allograft Rejection
- Mechanism of Action of
Viral IL-10 in a DTH Model
- Mechanisms of Rat Renal
Allograft Tolerance: The Role of In Situ Chimerism, Local TGF-ß and IL-2r
Expression
- Cytokine Expression In
Cardiac Allograft Tissue Using Mice Deficient In Intercellular Adhesion
Molecule-1 (ICAM-1) As Donors Or Recipients
- A Mutant IL-15 Protein
That Is A Specific Receptor Site Antagonist
- IFNy Is Necessary For
Acute Rejection of MHC Class II-Disparate Skin Allografts But Is Not Required
For MHC Class I Rejection
- Abrogation of Hyperacute
Skin Allograft Rejection In Presensitized Rats By Malononitrilamides (MNAs)
- Malononitrilamides (MNAs)
Regulate Alloreactivity In Vivo By Inhibition of T- and B-Cell Responsiveness
- Single Dose
Pharmacodynamic Effects of Cyclosporine (CsA) In Mouse and Human: Calcineurin
(CN) Inhibition Has Rapid "On" and "Off" Rates and Is Marked
In Kidney
- Long-Term Survival of
Segmental Pancreas Isografts In NOD/LT Mice Treated With Anti-CD4 and Anti-CD8
MAB.
Kidney-Pancreas:
Pediatric:
Allorecognition:
Costimulatory Pathways:
Chronic Rejection:
Peripheral Tolerance:
Tolerance:
Cytokines-Chemokines:
Xenotransplantation:
Graft Dysfunction:
Liver:
- The Impact of Transjugular
Intrahepatic Portosystemic Shunts on Liver Transplantation in a Single Center
- Long-Term Outcome After
Liver Transplantation
- Recurrence of Hepatitis C
Following Liver Transplant: Relationship to Primary Immunosuppression
- Liver Transplantation for
Alcoholic Liver Disease: Long-Term Results
- Successful Prednisone
Withdrawal after Liver Transplantation in Patients with Autoimmune Chronic
Active Hepatitis
- Alcohol Dependent Liver
Graft Recipients: A Controlled Three Year Follow-Up
- Prevention of CMV
Infection with High-Dose Acyclovir and IVIG Prophylaxis: A 5-Year Experience
- Tacrolimus (FK506) and
Mycophenolate Mofetil (MMF) Combination Therapy Versus Tacrolimus in Adult Liver
Transplantation
- The Impact of Utilization
of Older Donors on Clinical Features and Serial Histologic Changes Following
Orthotopic Liver Transplantation
- Comparison of Prograf with
Neoral as Primary Immunosuppression in Hepatitis C Patients after Orthotopic
Liver Transplantation
- Progression of HCV Viral
Load in Sera and Liver Biopsies After Orthotopic Liver Transplantation
- Mycophenolate Mofetil in
Combination with FK 506 and Steroids for Intestinal Transplantation
- Infectious Complications
Following OKT3 Induction in Liver Transplantation (LTX)
- Evaluation of Donor and
Recipient Factors on Early Graft Outcome Following Intestinal Transplantation
- Alcohol Use Among Patients
Transplanted for Alcoholic Cirrhosis
- Does Preoperative
Creatinine (Scr) Affect Outcome After Orthotopic Liver Transplantation (OLTx)?
- Hepatorenal Syndrome
(HRS): Why are Combined Liver Kidney Transplants Still Being Done?
- Neurologic Death Following
Liver Transplantation
- 10 Years of Liver
Transplantation: An Evolving Understanding of Late Graft Loss
- Does Recurrent Autoimmune
Hepatitis after Liver Transplant have an Impact on Patient and Graft Survival?
- Absence of Hepatitis G
Virus Within Liver Tissue of Patients Undergoing Liver Transplantation for
Cryptogenic Cirrhosis
- The Effect of Race and
Payer Status on Cost of Liver Transplantation
- Incidence of Recurrent HBV
Infection in Liver Transplant Recipients on Primary Tacrolimus Immunosuppression
- Tacrolimus vs Cyclosporine
in Liver Transplantation: Five-Year Follow Up of the U.S. Phase III,
Comparative, Randomized Study
- Infection in Orthotopic
Liver Transplantation Recipients: Impact on Resource Utilization and Outcome
- Regional Waiting Time
Differences: A UNOS Study of the Liver Waiting List
- T-Tube Vs Stent in Adult
Liver Transplantation
- Cytomegalovirus Immune
Globulin (CMVIG) Prophylaxis is Associated with Increased Survival after
Orthotopic Liver Transplantation
- Efficacy of Engerix-B
(Recombinant Hepatitis-B Vaccine) in Patients with Chronic Liver Disease
Awaiting Orthotopic Liver Transplantation (OLT)
- Relationship Between
Primary Sclerosing Cholangitis (PSC) & Ulcerative Colitis (UC) in Patients
Undergoing Orthotopic Liver Transplantation (OLT)
- Long Term Follow-up of
Liver Transplant Recipients Maintained on Cyclosporine without Corticosteroids
- Efficacy and Safety of Low
Dose Tacrolimus and Mycophenolate Mofetil in OLT Recipients
- "De Novo"
Hepatitis B Virus (HBV) Infection in Liver Transplant (LT) Recipients:
Incidence, Source of Infection and Long-Term Outcome
- Morphologic Classification
of Post-Transplant Lymphoproliferative Disorder in Liver Transplant Patients and
Its Role in Predicting Outcome
- Anti-FKBP12 Autoantibodies
as a Useful Predictor of Rejection Following Liver Transplantation
- CMV Detection by PCR
Identifies CMV Infection Earlier than Standard Culture in Liver Transplant
Recipients Who Develop CMV Disease
- Management of Inflammatory
Bowel Disease after Liver Transplantation
- Preemptive Therapy in
CMV-AG Positive Patients after Liver Transplantation - A Prospective Trial
- Searching for the Optimal
Management of Hepatitis C Patients After Liver Transplantation
- Dual Tacrolimus
Immunosuppression vs Quadruple Induction Therapy after Liver Transplantation -
Results of a Randomized Trial
- Incidence of Acute
Cellular Rejection (ACR) Depends on the Pre-Transplant (OLT) Diagnosis
- Successful Pregnancy,
Childbearing, and Child Development after Liver Transplantation
- Recurrent Hepatocellular
Carcinoma After Liver Transplantation
- Long-Term Follow-Up of
Patients Evaluated for Liver Transplantation Using a Method of Risk
Stratification for Estimating Recidivism.
- Infectivity of Hepatic
Allografts with Antibodies to Hepatitis B Virus
- Prednisone Withdrawal 14
Days After Liver Transplantation With Mycophenolate: A Prospective Trial of
Cyclosporine and Tacrolimus
- Levels of Mycophenolic
Acid and Its Glucuronide Derivative in the Plasma of Liver, Small Bowel, and
Kidney Transplant Patients Receiving Tacrolimus and Cellcept Combination Therapy
- The Limited (Negative)
Predictive Value of Selected Risk Factors in Liver Transplantation. An Analysis
of the UNOS Registry Data 1991-1995
- Outcome of Hepatitis C
Virus-Infected Primary Liver Transplants: 5-Year Follow-up of the U.S.,
Randomized, Comparative Study
- A Prospective Study of the
Conversion of Stable Liver Transplant Patients to Neoral
- Impact of Donor/Recipient
HLA Matching On Outcome and Recurrence of HBV Hepatitis After Orthotopic Liver
Transplantation (OLT)
- Dedection of Alcohol
Relapse in Patients Following OLT for Alcoholic Cirrhosis
- Low Incidence of Rejection
in Orthotopic Liver Transplantation Recipients with Impaired Renal Function and
Low Cyclosporine Levels
- Pharmacokinetics and
Immunodynamics of Simulect in Liver Transplant Recipients
- Pharmacokinetics of
Intravenous and Oral Mycophenolate Mofetil (MMF) in Liver Allograft Recipients
- A Prospective Randomized
Trial of Mycophenolate Mofetil (MMF) with Neoral or Tacrolimus Following
Orthotopic Liver Transplantation (OLT)
- Importance of Cyclosporine
Pharmacokinetics to Clinical Outcomes after Liver Transplantation
- Prospective Randomized
Trial of Tacrolimus and Prednisone vs. Tacrolimus, Prednisone and Mycophenolate
Mofetil in Primary Adult Liver Transplant Recipients
- A Randomized Trial
Comparing Quadruple Induction Therapy with Anti-IL2 Receptor Antibody or ATG
after Liver Transplantation
- Immunoprophylaxis with a
Chimeric Anti-IL-2R Monoclonal Antibody in Liver Transplanted Patients
- Posttransplant De Novo
Neoplasia in hepatic Allograft Recipients
Histocompatability:
Intrathoracic Organs:
Heart and Heart-Lung:
Ethics and Economics:
Bone Marrow: